The US Food and Drug Administration has approved TNKase or Tenecteplase, which is a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Ischemic strokes happen when a blood clot blocks a blood vessel in your brain. It can cause permanent brain damage and death. If enough brain cells die, you can also lose the abilities or body functions those cells control. They are also the most common types of stroke, with 80% of all strokes being ischemic strokes.

How is TNKase administered?

It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, which is administered as an intravenous bolus followed by a 60-minute infusion. The manufacturer of TNKase, Genetech said a new 25-mg vial configuration will also be available in the coming months.

How Was TNKase approved?

The approval came at the backdrop of a study that compared TNKase to Activase in patients with acute ischemic stroke. These patients also presented with a disabling neurological deficit. Results show that TNKase was comparable to Activase in terms of efficacy and safety.

How Common Are These Strokes?

In the United States it self, it affects more than 795,000 people each year and is the leading cause of long-term disability. It is also the fifth leading cause of death. Since brain damage can happen if this progresses rapidly, one needs an immediate, fast-acting medical care.

TNKase thus provide a faster and simpler administration which can be critical for anyone. The chief medical officer and head of global product development at Genetech, Levi Garraway, MD., PhD., said, "Today's approval is a significant step forward and underscores our commitment to advancing stroke treatment options for patients."

What Are The Symptoms Of Ischemic Strokes?

Some of the most common symptoms include weakness or paralysis on one side of your face and body. You may also feel trouble speaking or have loss of speech, also known as aphasia. You may faced slurred or garbled speaking, also known as dysarthria. Other symptoms include loss of muscle control on one side of your face, or sudden worsening or loss of your senses, including vision, hearing, smell, taste, and touch.

Other symptoms include:

• Loss of coordination or clumsiness
• Blurry vision or double vision
• Dizziness or vertigo
• Nausea and vomiting
• Neck stiffness
• Mood swings or sudden personality changes
• Confusion or agitation
• Seizures
• Memory loss (amnesia)
• Headaches which are sudden and severe
• Passing out or fainting
• Coma

Are There Any Warning Signs?

While these are symptoms one has who is prone to this condition. However, often, many may confuse it with other illnesses. It is best to keep an eye out for warning signs. These could be looking out for yourself or your loved one. Note if there is a sudden loss of balance. Look out for sudden vision loss or changes in one or both eyes. Look for a droop on one or both sides of your face, especially when you smile. Raise both arms and see if one arm sags or drops in a way it usually does not. Note for your speech. Are you as fluent? Are you have trouble speaking? If you see any of such signs, start tracking it and talk to your healthcare provider.

The UK is witnessing yet another outbreak of meningitis, with one college student dead and two others infected in Berkshire, according to the UK Health Security Agency (UKHSA).

According to the agency, close contacts of those affected are being offered antibiotics as a precautionary measure.

Also Read: Why Rebranding PCOS As PMOS Could Mark A New Era In Women’s Health

While stressing that the risk to the wider public remains low, the UKHSA confirmed that one case has been identified as Meningitis B (MenB), while further testing is ongoing.

The latest infections come after a small number of meningitis B cases were reported in the Weymouth region in April, followed by a major outbreak in Kent in March that affected more than 30 people and led to the deaths of a sixth-form pupil and a university student.

What’s The Meningitis Situation In Reading?

The young person who died attended The Henley College, according to a local GP surgery.

Authorities are reportedly sharing information about the infection with students and parents at affected schools. The other two cases are believed to be linked to schools in the Reading area. But the officials are yet to disclose the exact link.

Health officials said close contacts of the infected individuals are being offered antibiotics as a precaution.

Read More: Hantavirus Outbreak: Critically Ill French Patient On Artificial Lung Support

GP surgery, the Hart Surgery, based in Henley-on-Thames, stated that it was in contact with the UKHSA due to the college’s location, adding that the agency was “actively contacting those who may be at risk due to a close association with the student involved.”

However, it said anyone whom the UKHSA has not contacted does not require treatment, and students and staff can continue attending the sixth-form college as usual.

“The number of confirmed cases is very low, so there are currently no plans for a local emergency meningitis vaccination programme,” it added.

Also read: UK Reports Meningitis Outbreak Among School Children: All You Need To Know

What Is Meningitis?

Meningitis is a serious medical condition that affects the protective membranes covering the brain and spinal cord, known as the meninges. Fever is often considered one of the classic symptoms, although it may not always be present.

Understanding the symptoms, causes, and treatment options is important for early diagnosis and timely medical care.

“Anyone can get meningitis, and around 300 to 400 cases of meningococcal disease are diagnosed in England every year. It is most common in babies, young children, teenagers, and young adults," said Dr Rachel Mearkle, a consultant in health protection at the UKHSA.

“It needs to be treated quickly, so it is important to know the signs and symptoms. They can appear in any order and may not all be present, so seek rapid medical attention if there is ever any concern," she added.

The expert noted that "meningococcal meningitis requires very close contact to spread, and large outbreaks such as the one recently seen in Kent are thankfully rare."

“Meningococcal disease does not spread easily, and the risk to the wider public remains low.”

Symptoms Of Meningitis

Health officials urged the public to remain alert to the warning signs of meningococcal meningitis. Common symptoms include:

• Rash
• Headache
• Neck stiffness
• Fever
• Drowsiness
• Nausea or vomiting
• Increased sensitivity to light

“If the disease is suspected, immediate medical attention should be sought, as it can progress rapidly,” the officials said. While antibiotics provide the quickest short-term protection, vaccines offer longer-term protection.

Pancreatic cancer has long been one of the toughest challenges in oncology. With a five-year survival rate hovering around 13 per cent and recurrence rates approaching 80 per cent after treatment, the odds have historically been stacked against patients.

However, an experimental drug called daraxonrasib, developed by the US-based late-stage clinical oncology company Revolution Medicines, has shown promise in improving survival rates in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

“For patients with metastatic pancreatic cancer, new treatment options are urgently needed to increase survival time and improve quality of life,” said Brian M. Wolpin, professor of medicine at Harvard Medical School, and principal investigator for the trial.

Wolpin noted that the study “indicates that daraxonrasib provides a clear and highly meaningful step forward for patients with pancreatic cancer who have experienced progression on prior treatment, typically chemotherapy.”

What Is Daraxonrasib?

Daraxonrasib is a once-daily oral pill that demonstrated statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) compared with standard intravenous chemotherapy.

Daraxonrasib, described as a multi-selective inhibitor of RAS(ON) proteins, is the first investigational drug in a new class of RAS inhibitors designed to target a broad spectrum of cancer-causing RAS mutations.

In the clinical trial, daraxonrasib showed a median overall survival of 13.2 months, compared with 6.7 months for chemotherapy.

The drug was generally well tolerated and showed a manageable safety profile, with no new safety concerns identified.

Daraxonrasib works by blocking KRAS signalling proteins that drive tumor growth.

Pancreatic cancer is considered one of the most RAS-addicted cancers, with more than 90 per cent of patients carrying tumours driven by RAS protein mutations.

Also read: Former US Senator Ben Sasse Opens Up About Battle With Terminal Stage 4 Pancreatic Cancer

Daraxonrasib: The Clinical Trial

The controlled Phase 3 clinical trial evaluated daraxonrasib in patients with previously treated metastatic PDAC.

The trial included patients with pancreatic tumours carrying a wide range of RAS variants, as well as patients without identified RAS mutations.

The results showed that daraxonrasib significantly improved overall survival in patients with previously treated metastatic pancreatic cancer.

Similar RAS-targeting drugs are now being developed by other companies for pancreatic, lung, and colon cancers.

“It’s the beginning, not the end,” said Elizabeth Jaffee in comments to The New York Times.

What are the side effects?

According to the company, “Daraxonrasib was generally well tolerated, with a manageable safety profile and with no new safety signals.”

Prior studies with daraxonrasib have shown that rash is the most common side effect, with mouth sores, diarrhea, nausea, and vomiting also common.

Also read: India Gets Its First Alzheimer’s Drug: Know All About Eli Lilly’s Lormalzi

FDA fast-tracks Daraxonrasib

Based on the first interim analysis, all progression-free survival and overall survival results are now considered final.

Revolution Medicines said it plans to submit the data to global regulators, including the US Food and Drug Administration (FDA), as part of a future New Drug Application under a Commissioner’s National Priority Voucher.

The findings are also expected to be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

What Is Pancreatic Cancer? Know The Warning Signs

Pancreatic cancer typically begins in the ducts of the organ and can rapidly spread from there to the rest of the organ. Early-stage pancreatic tumors do not show up on imaging tests, making this version of the disease difficult to diagnose until it infects other organs.

The prevention and early detection remain vital.

Experts warn that pancreatic cancer often masquerades as common ailments, delaying diagnosis. Here are some early symptoms that should never be ignored:

• Abdominal or back pain that worsens over time or eases when leaning forward.
• Unexplained weight loss without changes in diet or exercise.
• Jaundice, including yellowing of the eyes and skin, sometimes with intense itching.
• Changes to urine or stool, such as dark urine or pale, greasy stools.
• New-onset diabetes without obvious risk factors.
• Persistent fatigue unrelated to poor sleep or lifestyle

A French woman infected with the deadly hantavirus outbreak linked to the MV Hondius cruise ship is critically ill and is being treated using an artificial lung.

The woman is among the passengers evacuated from Spain’s Canary Islands. According to the World Health Organization (WHO), 11 people have been affected by the rat-borne virus so far, of whom three have died.

A Dutch couple is believed to have been first exposed to the virus while visiting a birdwatching site in Argentina.

The WHO has confirmed that the Andes strain of hantavirus — the only strain known to spread from person to person — is behind the outbreak.

Patient Suffers Severe Lung And Heart Complications

The French passenger, currently hospitalized in Paris, has developed a severe form of the disease that has caused life-threatening lung and heart complications, Dr. Xavier Lescure, an infectious disease specialist at Bichat Hospital, told AP News Agency.

He explained that “the woman is on a life-support device that pumps blood through an artificial lung, providing it with oxygen and returning it to the body. The hope is that the device relieves enough pressure on the lungs and heart to give them some time to recover.”

Lescure described it as “the final stage of supportive care.”

With the evacuation of all passengers and many crew members completed, the MV Hondius is now sailing back to the Netherlands, where it will undergo cleaning and disinfection.

Also read: India Better Prepared For Hantavirus Outbreaks After COVID-19 Experience, Says Dr NK Ganguly | Exclusive

Hantavirus: No Pandemic Potential

Speaking to HealthandMe, Dr. Amitav Banerjee, professor at DY Patil Vidyapeeth, Pune, and former field epidemiologist in the Indian Armed Forces, said hantavirus does not spread easily from person to person.

Unlike COVID-19, it does not have significant aerosol or pandemic potential. Only certain strains, such as the Andes strain identified in South America, have shown limited person-to-person transmission, usually through very close or intimate contact involving body fluids.

“That is why the husband and wife may both have become infected. Even then, transmission is rare and requires prolonged close exposure. Basic precautions are generally sufficient, and asymptomatic individuals are unlikely to transmit the infection,” he said.

Dr. Amitav added that hantavirus does not have pandemic potential under natural conditions because it spreads poorly between humans and remains largely linked to rodent exposure.

Hantavirus: How to Prevent The Risk

Dr. Jatin Ahuja, Consultant in Infectious Diseases at Indraprastha Apollo Hospital, Delhi, told HealthandMe that the general public has no reason for alarm.

“Hantavirus infections remain rare globally, and awareness about rodent control and early symptom recognition continues to be the most effective approach,” he said.

He recommended simple preventive measures to significantly reduce risk.

“People should avoid sweeping or vacuuming rodent-infested areas directly, as this may spread contaminated particles into the air. Instead, affected areas should be ventilated first and cleaned using disinfectants while wearing gloves and masks. Proper storage of food, sealing entry points for rodents, and maintaining hygiene in homes, warehouses, and workplaces are also important preventive steps,” the expert added.